首页> 外文期刊>International journal of antimicrobial agents >Quinoline and cyanine dyes - putative anti-MRSA drugs [Review]
【24h】

Quinoline and cyanine dyes - putative anti-MRSA drugs [Review]

机译:喹啉和花青染料-推定的抗MRSA药物[综述]

获取原文
获取原文并翻译 | 示例
       

摘要

One way in which drug-resistant bacteria may be attacked is to screen new series of candidate compounds. Quaternary quinoline compounds and dyes were studied by Carl Browning (1887-1972) and Julius Cohen (1859-1935). A remarkable part of Browning and Cohen's work was the early development of structure-activity relationships for their series of compounds. Thus cationic species were found generally to be more effective antibacterials than neutrals or anionics, and the testing of partial or deconstructed active molecules was also carried out. Much of this work underpinned the fuller understanding of e.g. aminoacridine action developed by Adrien Albert (1907-1989), himself also a collaborator of Browning. Analysis of the activity of a range of compounds developed by Browning and Cohen suggests that these might again be examined as topical antimicrobials in the fight against methicillin-resistant S. aureus (MRSA) and other resistant bacteria. (C) 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. [References: 37]
机译:耐药菌可能受到攻击的一种方法是筛选一系列新的候选化合物。卡尔·布朗宁(1887-1972)和朱利叶斯·科恩(Julius Cohen)(1859-1935)研究了季喹啉化合物和染料。勃朗宁和科恩(Browning and Cohen)工作的杰出部分是他们一系列化合物的构效关系的早期发展。因此,通常发现阳离子物种比中性或阴离子表面活性剂更有效,而且还对部分或解构的活性分子进行了测试。这项工作中的大部分内容为对例如氨基ac啶的作用是由艾德里安·阿尔伯特(Adrien Albert,1907-1989)开发的,他本人也是勃朗宁的合作者。对Browning和Cohen开发的一系列化合物的活性的分析表明,在对抗耐甲氧西林的金黄色葡萄球菌(MRSA)和其他抗性细菌的斗争中,这些化合物可能会再次被视作局部抗菌剂。 (C)2003年Elsevier B.V.和国际化学疗法学会。版权所有。 [参考:37]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号